15 recruiting, 8 unknown, 3 active not recruiting, 3 completed. 10 Not applicable, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 10 | Unknown 4, Active not recruiting 2, Recruiting 2, Completed 1, Withdrawn 1 |
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
Follow Liquid Biopsy: new trials by email Literature Review of Liquid Biopsy trials Research Report on Liquid Biopsy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Setting Up ctDNA Analysis on Archived Plasma Samples ctDNA - Ovarian Cancer, Liquid Biopsy | Recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 50 | 2026-06-08 | 2026-09-11 | |
| A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers blood sampling - Intracranial Venous Blood, Brain Cancers | Recruiting | M.D. Anderson Cancer Center | 20 | 2026-04-13 | 2026-09-09 | |
| Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer Systemic immunotherapy - Bladder Cancer, Liquid Biopsy | Phase 2 | Recruiting | Tianjin Medical University Second Hospital | 53 | 2026-03-16 | 2026-05-26 |
| Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis Prostate Cancer (Diagnosis), Bone Metastasis | Recruiting | Xijing Hospital | 1000 | 2026-03-12 | 2026-04-28 | |
| Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma Multi-Component Liquid Biopsy for Urothelial Carcinoma - Urothelial Carcinoma (UC), Bladder (Urothelial, Transitional Cell) Cancer | Recruiting | Tianjin Medical University Second Hospital | 300 | 2026-03-01 | 2026-03-02 | |
| Guiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Cancer Second Transurethral Resection of Bladder Tumor (re-TURBT), utDNA Testing (Urine Tumor DNA Detection) - Bladder Cancer, Liquid Biopsy | Not applicable | Recruiting | Tianjin Medical University Second Hospital | 196 | 2025-09-28 | 2026-08-14 |
| Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer utDNA testing + Urine Cytology, Cystoscopy + Urine Cytology - Bladder Cancer, Liquid Biopsy | Not applicable | Active not recruiting | Tianjin Medical University Second Hospital | 360 | 2025-09-20 | 2026-09-28 |
| The Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of High-risk Non-muscle Invasive Bladder Cancer urine tumor DNA/RNA testing - Bladder Cancer, Liquid Biopsy | Recruiting | Tianjin Medical University Second Hospital | 60 | 2025-09-01 | 2026-03-03 | |
| Clinical Studies of Endometrial Cytology and Cervical Methylation Assays in Endometrial Cancer Screening and Fertility-Preservation Evaluation Endometrial Cytology Testing, Cervical Methylation Testing - Endometrial Cancer, Methylation | Not yet recruiting | Yulan Ren | 200 | 2024-11-04 | 2024-11-05 | |
| French Assessment of MRD by Liquid Biopsies in Colorectal With Liver Metastasis Patients (FRENCH.MRD.CRLM) Blood sample/Liquid biopsy - Colorectal Cancer, Liver Metastases | Recruiting | University Hospital, Montpellier | 30 | 2024-04-15 | 2026-06-22 | |
| French Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC) Blood sample/lliquid biopsy - Colorectal Cancer, Stage III Colon Cancer | Recruiting | University Hospital, Montpellier | 70 | 2024-04-11 | 2026-08-18 | |
| French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC) Blood sample/Liquid Biopsy - Pancreatic Cancer Resectable, Pancreatic Ductal Adenocarcinoma | Recruiting | University Hospital, Montpellier | 37 | 2024-03-01 | 2025-07-10 | |
| Investigation of Urinary Biomarkers for the Detection of Prostate Cancer Colli-Pee UAS devices - Prostate Cancer, Urine | Not applicable | Withdrawn | Novosanis NV | 2023-12-01 | 2023-11-13 | |
| Liver Cancer and Immunotherapy in the Liquid Biopsy Era Liquid Biopsy - Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma | Not applicable | Recruiting | University Hospital, Montpellier | 60 | 2023-06-28 | 2025-07-10 |
| A Liquid Biopsy Diagnostic Techniques for Endometriosis Three-Dimensional Poly(dimethylsiloxane) Scaffold - Liquid Biopsy, Endometriosis | Unknown | Tongji Hospital | 40 | 2023-04-10 | 2024-02-28 | |
| Investigation of Urinary Biomarkers for the Detection of Breast Cancer Colli-Pee UAS devices - Breast Cancer, Urine | Not applicable | Unknown | Novosanis NV | 200 | 2022-12-21 | 2023-03-24 |
| MONOCENTRIC PERSPECTIVE STUDY: USE OF LIQUID BIOPSY WITH DIAGNOSTIC IMAGING Liquid Biopsy - Breast Cancer, Liquid Biopsy | Unknown | University of Campania Luigi Vanvitelli | 200 | 2022-09-12 | 2022-11-21 | |
| Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors Focused Ultrasound (Exablate Model 4000) - Glioblastoma, Glioma | Not applicable | Completed | InSightec | 71 | 2022-08-08 | 2025-07-28 |
| The Jinling Cohort MERCURY test, health questionnaires and annual routine physical exams - Cancer, Multi Cancer Early Screening | Recruiting | Nanjing Shihejiyin Technology, Inc. | 15000 | 2022-06-15 | 2023-08-25 | |
| Combing a Deep Learning-Based Radiomics With Liquid Biopsy for Preoperative and Non-invasive Diagnosis of Glioma Prediction of glioma grading and molecular subtype - Glioma (Diagnosis), Liquid Biopsy | Completed | Second Affiliated Hospital of Nanchang University | 68 | 2022-05-01 | 2026-10-20 |
Showing 20 of 31. Sign in to see all of them.
Neoplasms (5) · Breast Neoplasms (4) · Urinary Bladder Neoplasms (4) · Colorectal Neoplasms (3) · Disease (3) · Endometrial Neoplasms (3) · Neoplasm, Residual (3) · Prostatic Neoplasms (3) · Brain Neoplasms (2) · Carcinoma, Hepatocellular (2) · Glioma (2) · Melanoma (2) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Ovarian Epithelial (1) · Carcinoma, Transitional Cell (1)
Neoplasms (25) · Neoplasms by Site (25) · Urogenital Diseases (14) · Urogenital Neoplasms (12) · Female Urogenital Diseases (10) · Female Urogenital Diseases and Pregnancy Complications (10) · Genital Diseases (10) · Neoplasms by Histologic Type (10) · Neoplasms, Glandular and Epithelial (8) · Male Urogenital Diseases (7) · Pathologic Processes (7) · Pathological Conditions, Signs and Symptoms (7) · Carcinoma (6) · Genital Diseases, Female (6) · Skin Diseases (6)
Blood Specimen Collection (6) · Liquid Biopsy (4) · Biopsy (1) · Circulating Tumor DNA (1) · Cystoscopy (1)
Tianjin Medical University Second Hospital (5) · University Hospital, Montpellier (4) · Lei Li (3) · Novosanis NV (3) · Regina Elena Cancer Institute (3) · Erasmus Medical Center (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · Gene Solutions (1) · InSightec (1) · M.D. Anderson Cancer Center (1) · Nanjing Shihejiyin Technology, Inc. (1) · Second Affiliated Hospital of Nanchang University (1) · Tongji Hospital (1) · University Health Network, Toronto (1) · University Hospital, Bordeaux (1)
China (12) · France (5) · Italy (5) · Belgium (3) · Canada (2) · United States (2) · Netherlands (1) · Vietnam (1)
Lei Li, M.D. (3) · Andres M. Lozano, MD, PhD (1) · Anne-Marie Dingemans, MD, PhD (1) · Camilla Nero (1) · Christopher C Young, MD (1) · Gelareh Zadeh, MD, PhD (1) · Qianxue Chen (1) · Shao Yang, Ph.D (1) · Thomas Bardol, M.D. (1) · Xingen Zhu, Prof (1)
PMID 33138052, PMID 37201155, PMID 38096473, PMID 38615940, PMID 39948555